Adicet Bio, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Adicet Bio, Inc. (ACET) on December 26, 2025, regarding events occurring on that date and effective December 30, 2025. The filing details the implementation of a reverse stock split previously approved by stockholders at a Special Meeting held on December 19, 2025.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance and capital structure adjustments.
Material Changes
- Reverse Stock Split: The Company effected a 1-for-16 reverse stock split of its Common Stock. Every 16 outstanding shares were reclassified into one new share.
- Effective Date: The split became effective at 12:01 a.m. Eastern Time on December 30, 2025.
- Trading Adjustments: Trading on The Nasdaq Capital Market commenced on a split-adjusted basis on December 30, 2025, under the existing symbol "ACET" with a new CUSIP number (007002207).
- Equity Adjustments: Proportional adjustments were made to shares available under equity incentive plans, exercise prices of stock options, and terms of outstanding warrants.
- Fractional Shares: No fractional shares were issued; holders entitled to fractional shares received cash in lieu thereof.
Guidance, Outlook, and Risks
The filing includes standard forward-looking statements regarding the expected effects of the reverse stock split on trading. Management highlighted risks including global economic conditions, public health crises, regulatory approval timelines, clinical study outcomes, and the ability to raise additional capital. The Company explicitly stated it undertakes no duty to update forward-looking statements unless required by law.
Investor Verification Checklist
- Verify the new CUSIP number (007002207) for the Common Stock.
- Confirm the adjusted share count and exercise prices for any held stock options or warrants.
- Review the treatment of fractional shares if applicable to the investor's specific holding.
- Monitor trading activity on The Nasdaq Capital Market starting December 30, 2025, under the symbol ACET.